Clinical Trial Update: Niraparib Combined With Brivanib or Toripalimab in Patients With Cervical Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial investigating Niraparib with Brivanib or Toripalimab in cervical cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Cancer

Drugs mentioned

• Brivanib (brivanib)
• Niraparib (Niraparib)
• Toripalimab (Toripalimab)

Snippet

Sponsor: Chongqing University Cancer Hospital | Conditions: Cervical Cancer | Phase 2 | Status: UNKNOWN